Dr David Mark Rafalko, MD | |
1301 Riverside Dr, Beaver, PA 15009-3116 | |
(724) 728-7800 | |
(724) 728-8115 |
Full Name | Dr David Mark Rafalko |
---|---|
Gender | Male |
Speciality | Otolaryngology - Otolaryngology/facial Plastic Surgery |
Location | 1301 Riverside Dr, Beaver, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558368704 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207YX0905X | Otolaryngology - Otolaryngology/facial Plastic Surgery | MD016925E (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr David Mark Rafalko, MD 1301 Riverside Dr, Beaver, PA 15009-3116 Ph: (724) 728-7800 | Dr David Mark Rafalko, MD 1301 Riverside Dr, Beaver, PA 15009-3116 Ph: (724) 728-7800 |
News Archive
In stark contrast to normal cells, which only divide a finite number of times before they enter into a permanent state of growth arrest or simply die, cancer cells never cease to proliferate. Now, scientists at the Salk Institute for Biological Studies have uncovered an important clue to one of the mechanisms underlying cancer cell immortality.
A clinical study of 30 adult patients with multiple sclerosis (MS) at the University of California, San Diego School of Medicine has shown that smoked cannabis may be an effective treatment for spasticity - a common and disabling symptom of this neurological disease.
NextBio, provider of an innovative platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data, announced that the University of Southern California (USC) has licensed NextBio Enterprise for research use by students and faculty. The University plans to promote use of the NextBio research platform campus-wide beginning in August.
A visiting international rehabilitation expert has called for Hypnotic Therapy to be considered a ‘mainstream' treatment option in the management of chronic pain, potentially benefiting thousands of Australian pain sufferers.
› Verified 4 days ago